Squire JD - Search Results

1

Statistical Mechanics Metrics in Pairing and Parsing In Silico and Phenotypic Data of a Novel Genetic NFκB1 (c.T638A) Variant.

Chaudhri EN, Abbott JM, Islam NN, Weber CA, Coban MA, Bilgili A, Squire JD, Mantia S, Wierenga KJ, Caulfield TR. Chaudhri EN, et al. Among authors: squire jd. Genes (Basel). 2023 Sep 24;14(10):1855. doi: 10.3390/genes14101855. Genes (Basel). 2023. PMID: 37895204 Free PMC article.

2

Clinical and Phenotypic Characterization of Common Variable Immunodeficiency Diagnosed in Younger and Older Adults.

Fortier JC, Haltigan E, Cavero-Chavez V, Gomez-Manjarres D, Squire JD, Reeves WH, Cuervo-Pardo L. Fortier JC, et al. Among authors: squire jd. J Clin Immunol. 2022 Aug;42(6):1270-1279. doi: 10.1007/s10875-022-01290-w. Epub 2022 May 19. J Clin Immunol. 2022. PMID: 35588029

3

Disseminated mycobacterial infections after tumor necrosis factor inhibitor use, revealing inborn errors of immunity.

Squire JD, Libertin CR, Powers H, Nelson J, Brumble L, Laham FR, Agharahimi A, Freeman AF, Leiding JW. Squire JD, et al. Int J Infect Dis. 2023 Jun;131:162-165. doi: 10.1016/j.ijid.2023.04.007. Epub 2023 Apr 8. Int J Infect Dis. 2023. PMID: 37037391 Free PMC article.

4

Assessment of Sleep Disorders in Patients with CVID.

Punj M, Neshat SS, Mateus AYL, Cheung J, Squire JD. Punj M, et al. Among authors: squire jd. J Clin Immunol. 2024 Apr 27;44(5):109. doi: 10.1007/s10875-024-01711-y. J Clin Immunol. 2024. PMID: 38676767

5

Safety and tolerability of Evusheld in patients with CVID: The Mayo Clinic experience.

Squire JD, Pitlick MM, Freeman CM, Joshi AY. Squire JD, et al. J Allergy Clin Immunol Glob. 2023 May;2(2):100081. doi: 10.1016/j.jacig.2023.100081. Epub 2023 Feb 8. J Allergy Clin Immunol Glob. 2023. PMID: 36777105 Free PMC article.

6

Response to mRNA COVID-19 vaccination in three XLA patients.

Squire JD, Joshi AY. Squire JD, et al. Vaccine. 2022 Aug 26;40(36):5299-5301. doi: 10.1016/j.vaccine.2022.07.046. Epub 2022 Aug 3. Vaccine. 2022. PMID: 35934578 Free PMC article.

7

Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies.

Squire JD, Joshi AY. Squire JD, et al. J Clin Immunol. 2021 Oct;41(7):1527-1530. doi: 10.1007/s10875-021-01101-8. Epub 2021 Jul 22. J Clin Immunol. 2021. PMID: 34291391 Free PMC article. No abstract available.

8

Immunoglobulin treatment for B-cell immunodeficiencies.

Freeman CM, Squire JD, Joshi AY. Freeman CM, et al. Among authors: squire jd. J Immunol Methods. 2022 Oct;509:113336. doi: 10.1016/j.jim.2022.113336. Epub 2022 Aug 11. J Immunol Methods. 2022. PMID: 35964701

9

An Expert Opinion/Approach: Clinical Presentations, Diagnostic Considerations, and Therapeutic Options for Gastrointestinal Manifestations of Common Variable Immune Deficiency.

Hashash JG, Squire J, Francis FF, Binion DG, Cross RK, Farraye FA. Hashash JG, et al. Am J Gastroenterol. 2022 Nov 1;117(11):1743-1752. doi: 10.14309/ajg.0000000000002027. Am J Gastroenterol. 2022. PMID: 36148549 Review.

10

IgG replacement in multiple myeloma.

Wonnaparhown A, Hilal T, Squire J, Freeman C, Fonseca R. Wonnaparhown A, et al. Blood Cancer J. 2024 Jul 25;14(1):124. doi: 10.1038/s41408-024-01107-6. Blood Cancer J. 2024. PMID: 39054331 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters